Crossmark

Chitosan-Based Nanoformulations: Preclinical Investigations, Theranostic Advancements, and Clinical Trial Prospects for Targeting Diverse Pathologies

Published Online: 2024-11-05

Authors

Yadav, Seema

Singh, Abhishek

Palei, Narahari N. https://orcid.org/0000-0002-2041-1849
Pathak, Prateek

Verma, Amita

Yadav, Jagat Pal https://orcid.org/0000-0001-8386-9825
License Information

Text and Data Mining valid from 2024-11-05

Version of Record valid from 2024-11-05
More Information

Article History

Received: 30 April 2024

Accepted: 15 September 2024

First Online: 5 November 2024

Declarations

:

: The authors declare no competing interest.

Document is current